| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Witte Owen N. is a Director at Allogene Therapeutics, Inc.. Recent SEC Form 4 filings include 1 buy and 9 sells.
Estimated insider holdings value: $668K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2022 | ALLO Allogene Therapeutics, Inc. | Director | Sell | 15,000 | $16.75 | $251,250.00 | -3.3% | -44.7% | -75.7% | |
| Aug 12, 2022 | ALLO Allogene Therapeutics, Inc. | Director | Sell | 15,000 | $16.75 | $251,250.00 | -3.3% | -44.7% | -75.7% | |
| Jun 22, 2022 | ALLO Allogene Therapeutics, Inc. | Director | Sell | 10,000 | $11.76 | $117,600.00 | -4.1% | +11.6% | -60.7% | |
| Sep 9, 2021 | ALLO Allogene Therapeutics, Inc. | Director | Sell | 5,000 | $25.54 | $127,700.00 | -2.2% | -25.1% | -40.3% | |
| Aug 20, 2021 | ALLO Allogene Therapeutics, Inc. | Director | Sell | 10,000 | $23.47 | $234,700.00 | -2.1% | -23.0% | -36.8% | |
| Jun 9, 2021 | ALLO Allogene Therapeutics, Inc. | Director | Sell | 9,969 | $25.05 | $249,723.45 | -4.0% | +2.1% | -56.8% | |
| Oct 15, 2018 | ALLO Allogene Therapeutics, Inc. | Director | Buy | 15,000 | $18.00 | $270,000.00 | +8.2% | - | - |